Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schieffelin Institute of Health-Research and Leprosy Center (SIHRLC), located in Karigiri, Tamil Nadu, India, is a premier research institute, training center, and general hospital dedicated to the care, treatment, and elimination of leprosy. Established in 1955, the institute has evolved from a specialized leprosy sanatorium into a 150-bed integrated health facility that provides comprehensive medical care, reconstructive surgery, and rehabilitation services. SIHRLC is globally recognized for its contributions to leprosy research, including molecular biology, immunology, and the implementation of Multi-Drug Therapy (MDT). The center also operates the College of Health Sciences, training allied health professionals to address leprosy and other public health challenges. Through collaborations with international organizations like the World Health Organization, SIHRLC continues to be a beacon of hope and a leader in global health initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schieffelin Institute of Health-Research and Leprosy Center.